Talk Bio

Co-Diagnostics Initiates Clinical Evaluations for Upper Respiratory Multiplex Point-of-Care Test on Co-Dx PCR Platform to Support Submission to the U.S. FDA

Lilly's Oral GLP-1, Orforglipron, Achieves Two New Clinical Wins in Type 2 Diabetes

Akeso Scores Two Wins in Phase 3 Trials, Tees Up Regulatory Submissions in China

Regeneron Reports Phase 3 Success for Cemdisiran in Rare Disease Generalized Myasthenia Gravis

Lilly's Q2 2025 Beat-and-Raise Overshadowed by Orforglipron Data